What Makes a Potent Nitrosamine? Statistical Validation of Expert-Derived Structure-Activity Relationships

Area of Science:

• Medicinal Chemistry
• Computational Toxicology
• Pharmaceutical Analysis

Background:

• Carcinogenic nitrosamine impurities exceed safe limits in pharmaceuticals, necessitating robust analytical methods.
• Existing structure-activity relationship (SAR) analyses face challenges with limited datasets and confounding structural features.
• Accurate SAR requires statistically significant identification of individual substructural effects on potency.

Purpose of the Study:

• To develop a statistically robust method for analyzing SAR of nitrosamine impurities.
• To overcome limitations of traditional SAR and quantitative structure-activity relationship (QSAR) methods on small datasets.
• To identify specific structural features influencing carcinogenic potency in nitrosamines.

Main Methods:

• A novel Bayesian multiple linear regression approach was employed.
• The method estimates the simultaneous and independent effects of each structural feature.
• It accounts for feature combinations and mitigates the impact of multiple testing.

Main Results:

• The Bayesian method successfully identified statistically significant structural features impacting nitrosamine potency.
• It provides robust validation for expert SAR assessments of nitrosamine potency differences.
• Specific structural features correlating with high and low carcinogenic potency were isolated.

Conclusions:

• The proposed Bayesian method enables accurate SAR analysis even with limited data.
• It allows for precise categorization of novel nitrosamine compounds based on their predicted potency.
• This approach enhances the safety evaluation of pharmaceuticals by identifying critical structural determinants of nitrosamine carcinogenicity.